It is one of the most watched assets in the GLP-1 pipeline because it may push efficacy beyond current injectable therapies
A 2025 post-hoc analysis of the SURMOUNT trial found tirzepatide produced approximately 20% weight loss in postmenopausal women, with a 20cm reduction in waist circumference, consistent with results in premenopausal women
Wirtz M, Birke H, Heeg C, Mller C, Hosp F, Throm C, Knig S, Feldman-Salit A, Rippe K, Petersen G, Wade RC, Rybin V, Scheffze K, Hell R (2010) Structure and function of the hetero-oligomeric cysteine synthase complex in plants
Were here to offer education and curation, making it easier to find what you need and embrace your own wellness journeyyour way
Whats the difference between brand-name and compounded semaglutide
suited to pure injury recovery Klow Blend adds KPV immune modulation on top of all Glow Blend components